Literature DB >> 19271150

Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

Lenka Frol'ová1, Karel Smetana, Dana Borovská, Andrea Kitanovicová, Klára Klimesová, Ivana Janatková, Karin Malícková, Milan Lukás, Pavel Drastich, Zdenek Benes, Ludmila Tucková, Joachim C Manning, Sabine André, Hans-Joachim Gabius, Helena Tlaskalová-Hogenová.   

Abstract

OBJECTIVE: It is an open question whether multifunctional galectin-3 can be a serum marker in inflammatory bowel disease.
METHODS: Western blots and commercial ELISA detected and quantitated the lectin immunocytochemistry using double labeling localized it in tissue sections.
RESULTS: Serum concentrations were significantly increased in specimen of patients with active and remission-stage ulcerative colitis and Crohn's disease, associated with emerging positivity of CD14(+) cells.
CONCLUSION: Enhanced concentration of galectin-3 in serum reflects presence of disease and points to its involvement in the pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19271150     DOI: 10.1007/s00011-009-0016-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  50 in total

1.  Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities.

Authors:  P D Smith; L E Smythies; M Mosteller-Barnum; D A Sibley; M W Russell; M Merger; M T Sellers; J M Orenstein; T Shimada; M F Graham; H Kubagawa
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

2.  The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells.

Authors:  Erika Jensen-Jarolim; Regina Gscheidlinger; Georg Oberhuber; Czilla Neuchrist; Trevor Lucas; Giovanna Bises; Christian Radauer; Martin Willheim; Otto Scheiner; Fu-Tong Liu; George Boltz-Nitulescu
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 2.566

Review 3.  Development of the intestinal mucosal barrier.

Authors:  W Allan Walker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002 May-Jun       Impact factor: 2.839

4.  Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries.

Authors:  E Jensen-Jarolim; C Neumann; G Oberhuber; R Gscheidlinger; C Neuchrist; W Reinisch; R I Zuberi; E Penner; F T Liu; G Boltz-Nitulescu
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 5.  Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics.

Authors:  F Shanahan
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

6.  Dextran sodium sulfate-induced colitis causes rapid bone loss in mice.

Authors:  Gilad Hamdani; Yankel Gabet; Daniel Rachmilewitz; Fanny Karmeli; Itai Bab; Rivka Dresner-Pollak
Journal:  Bone       Date:  2008-07-14       Impact factor: 4.398

7.  Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes.

Authors:  Nisar Ahmad; Hans-J Gabius; Sabine André; Herbert Kaltner; Subramanian Sabesan; René Roy; Bingcan Liu; Frank Macaluso; C Fred Brewer
Journal:  J Biol Chem       Date:  2003-12-12       Impact factor: 5.157

Review 8.  Inflammatory bowel disease: progress and current concepts of etiopathogenesis.

Authors:  Franco Scaldaferri; Claudio Fiocchi
Journal:  J Dig Dis       Date:  2007-11       Impact factor: 2.325

9.  Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years).

Authors:  Rája Lodinová-Zádníková; Bozena Cukrowska; Helena Tlaskalova-Hogenova
Journal:  Int Arch Allergy Immunol       Date:  2003-07       Impact factor: 2.749

10.  Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.

Authors:  Sabine André; Hugo Sanchez-Ruderisch; Hiroaki Nakagawa; Malte Buchholz; Jürgen Kopitz; Pia Forberich; Wolfgang Kemmner; Corina Böck; Kisaburo Deguchi; Katharia M Detjen; Bertram Wiedenmann; Magnus von Knebel Doeberitz; Thomas M Gress; Shin-Ichiro Nishimura; Stefan Rosewicz; Hans-Joachim Gabius
Journal:  FEBS J       Date:  2007-05-29       Impact factor: 5.542

View more
  18 in total

Review 1.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

Review 2.  Soluble IgE receptors--elements of the IgE network.

Authors:  Barbara Platzer; Floortje Ruiter; John van der Mee; Edda Fiebiger
Journal:  Immunol Lett       Date:  2011-09-06       Impact factor: 3.685

3.  Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.

Authors:  Bojana Simovic Markovic; Aleksandar Nikolic; Marina Gazdic; Sanja Bojic; Ljubica Vucicevic; Milica Kosic; Slobodanka Mitrovic; Milos Milosavljevic; Gurdyal Besra; Vladimir Trajkovic; Nebojsa Arsenijevic; Miodrag L Lukic; Vladislav Volarevic
Journal:  J Crohns Colitis       Date:  2016-01-19       Impact factor: 9.071

4.  Galectin-3 in cord blood of term and preterm infants.

Authors:  M Demmert; K Faust; M K Bohlmann; B Tröger; W Göpel; E Herting; C Härtel
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

5.  The Role of Glycosylation in Inflammatory Diseases.

Authors:  Inês Alves; Manuel M Vicente; Ana M Dias; Joana Gaifem; Cláudia Rodrigues; Ana Campar; Salomé S Pinho
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

6.  Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis.

Authors:  Hwei-Fang Tsai; Chien-Sheng Wu; Yi-Lin Chen; Hsiu-Jung Liao; I-Tsu Chyuan; Ping-Ning Hsu
Journal:  J Mol Med (Berl)       Date:  2015-12-02       Impact factor: 4.599

Review 7.  Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.

Authors:  R K Boyapati; A G Rossi; J Satsangi; G-T Ho
Journal:  Mucosal Immunol       Date:  2016-03-02       Impact factor: 7.313

8.  Cord blood neutrophils display a galectin-3 responsive phenotype accentuated by vaginal delivery.

Authors:  Martina Sundqvist; Veronica Osla; Bo Jacobsson; Anna Rudin; Karin Sävman; Anna Karlsson
Journal:  BMC Pediatr       Date:  2013-08-21       Impact factor: 2.125

9.  Proteomic changes of alveolar lining fluid in illnesses associated with exposure to inhaled non-infectious microbial particles.

Authors:  Laura Teirilä; Kirsi Karvala; Niina Ahonen; Henrik Riska; Anne Pietinalho; Päivi Tuominen; Päivi Piirilä; Anne Puustinen; Henrik Wolff
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

10.  Immunohistochemical Studies on Galectin Expression in Colectomised Patients with Ulcerative Colitis.

Authors:  Mattias Block; Johan Mölne; Hakon Leffler; Lars Börjesson; Michael E Breimer
Journal:  Biomed Res Int       Date:  2016-01-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.